ConvaTec Group Plc (CNVVF)
USD 2.89
(0.0%)
USD 2.89
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.2 Billion USD | 8.99% |
| 2022 | 1.1 Billion USD | -1.71% |
| 2021 | 1.12 Billion USD | 10.24% |
| 2020 | 1.01 Billion USD | 6.61% |
| 2019 | 955.6 Million USD | 5.71% |
| 2018 | 903.95 Million USD | -5.04% |
| 2017 | 951.88 Million USD | 17.92% |
| 2016 | 807.25 Million USD | 1.44% |
| 2015 | 795.79 Million USD | -12.32% |
| 2014 | 907.6 Million USD | -3.96% |
| 2013 | 945 Million USD | 4.4% |
| 2012 | 905.2 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 312.1 Million USD | 0.0% |
| 2024 Q1 | 312.1 Million USD | -48.06% |
| 2023 Q4 | 600.83 Million USD | 97.61% |
| 2023 FY | 1.2 Billion USD | 8.99% |
| 2023 Q1 | 299.3 Million USD | -46.16% |
| 2023 Q2 | 600.48 Million USD | 100.63% |
| 2023 Q3 | 304.05 Million USD | -49.37% |
| 2022 FY | 1.1 Billion USD | -1.71% |
| 2022 Q4 | 555.93 Million USD | 100.77% |
| 2022 Q3 | 276.9 Million USD | -45.83% |
| 2022 Q2 | 511.16 Million USD | 81.39% |
| 2022 Q1 | 281.8 Million USD | -49.04% |
| 2021 Q2 | 541.94 Million USD | 95.12% |
| 2021 FY | 1.12 Billion USD | 10.24% |
| 2021 Q1 | 277.75 Million USD | -48.75% |
| 2021 Q3 | 284.15 Million USD | -47.57% |
| 2021 Q4 | 552.97 Million USD | 94.61% |
| 2020 FY | 1.01 Billion USD | 6.61% |
| 2020 Q2 | 473.43 Million USD | 92.61% |
| 2020 Q3 | 264.25 Million USD | -44.18% |
| 2020 Q4 | 541.96 Million USD | 105.1% |
| 2020 Q1 | 245.8 Million USD | -52.07% |
| 2019 Q1 | 229.6 Million USD | -7.01% |
| 2019 FY | 955.6 Million USD | 5.71% |
| 2019 Q4 | 512.82 Million USD | 106.62% |
| 2019 Q3 | 248.2 Million USD | -44.02% |
| 2019 Q2 | 443.39 Million USD | 93.12% |
| 2018 Q2 | 241.65 Million USD | 0.0% |
| 2018 Q1 | 241.65 Million USD | -6.01% |
| 2018 FY | 903.95 Million USD | -5.04% |
| 2018 Q4 | 246.9 Million USD | 0.0% |
| 2018 Q3 | 246.9 Million USD | 2.17% |
| 2017 Q3 | 257.1 Million USD | 17.48% |
| 2017 Q2 | 218.85 Million USD | 0.0% |
| 2017 Q1 | 218.85 Million USD | -11.09% |
| 2017 Q4 | 257.1 Million USD | 0.0% |
| 2017 FY | 951.88 Million USD | 17.92% |
| 2016 Q3 | 246.15 Million USD | 15.18% |
| 2016 Q1 | 203.9 Million USD | -8.07% |
| 2016 Q4 | 246.15 Million USD | 0.0% |
| 2016 Q2 | 213.7 Million USD | 4.81% |
| 2016 FY | 807.25 Million USD | 1.44% |
| 2015 FY | 795.79 Million USD | -12.32% |
| 2015 Q4 | 221.8 Million USD | 3.26% |
| 2015 Q3 | 214.8 Million USD | 1.32% |
| 2015 Q2 | 212 Million USD | 3.72% |
| 2015 Q1 | 204.4 Million USD | -1.97% |
| 2014 Q1 | 217.2 Million USD | -15.35% |
| 2014 FY | 907.6 Million USD | -3.96% |
| 2014 Q2 | 240.6 Million USD | 10.77% |
| 2014 Q4 | 208.5 Million USD | -15.72% |
| 2014 Q3 | 247.4 Million USD | 2.83% |
| 2013 Q3 | 249 Million USD | 3.66% |
| 2013 Q2 | 240.2 Million USD | 19.27% |
| 2013 FY | 945 Million USD | 4.4% |
| 2013 Q4 | 256.6 Million USD | 3.05% |
| 2013 Q1 | 201.4 Million USD | -23.31% |
| 2012 Q4 | 262.6 Million USD | 16.4% |
| 2012 Q3 | 225.6 Million USD | 0.0% |
| 2012 FY | 905.2 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -70708.007% |
| Ansell Limited | 624.8 Million USD | -92.558% |
| Ansell Limited | 624.8 Million USD | -92.558% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -955.892% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -890725.074% |
| Psykey, Inc. | 415.97 Thousand USD | -289124.331% |
| ConvaTec Group Plc | 1.17 Billion USD | -2.409% |
| Encision Inc. | 3.13 Million USD | -38264.744% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -151421.928% |
| LifePoint, Inc. | -71.35 Thousand USD | 1686111.105% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 918499.85% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -229062.629% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -199340.323% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -201620.564% |
| SmileDirectClub, Inc. | 275.84 Million USD | -336.149% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | -33.57% |
| SheerVision, Inc. | 2.17 Million USD | -55192.009% |
| United Health Products, Inc. | -4857.00 USD | 24770612.744% |
| Vasamed, Inc. | -69.38 Thousand USD | 1733978.774% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -449384.54% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -2284910.643% |